Benzylpenicillin (Penicillin G)

  • Description and indication for use

    Benzylpenicillin is an antibacterial, useful in the treatment of most gram +ve and gram -ve organisms.  It is also effective against spirochaetes.

    Dose

    Usual dose in neonates60 mg/kg/dose 
    GBS Septicaemia 60 mg/kg/dose 
    GBS Meningitis 120 mg/kg/dose 
    VLBW 12 hourly 
    Term 

       Week 1

       Weeks 2 to 4

       >4 weeks

    12 hourly

    8 hourly

    4 to 6 hourly

    Reconstitution/Dilution 

    Vial = 600 mg.

    IV:

    Add 5.6 mL of water for injection = 100 mg/mL.

    IM:

    Add 1.6 mL of water for injection = 300 mg/mL.

    Route and method of administration

    IV:

    Doses can be given as a slow bolus over 3 minutes. Do not exceed 300 mg/minute.

    Side effects

    High doses may cause CNS toxicity including lethargy, twitching and seizures.

    Disturbances to serum electrolytes.

    Note: 600mg vial contains 1.7 mmol of sodium.

    Incompatibilities

    Benzylpenicillin may not be mixed together with the following drugs: Amphotericin B, heparin sodium (high concentration), sodium bicarbonate, insulin, phenytoin sodium, vancomycin.

    Special considerations

    Caution in patients with poor renal function.

    Caution in hypernatraemic patients due to high sodium content.

    Inactivates aminoglycosides (e.g. gentamicin), therefore preferably separate doses by an hour. If not possible to separate doses, flush line well with sodium chloride 0.9% before and after giving doses.

    Drug interactions

    Ensure that gentamicin levels are monitored when used in combination with Benzylpenicillin, especially in patients with poor renal function.

    Nursing responsibilities

    Observe for side effects.

    References:        

    1.             RCH Paediatric Pharmacopoeia, 13th ed. 2002.

    2.             RWH Neonatal Pharmacopoeia, 2nd ed. 2005.

    3.             RCH Paediatric Injectable Guidelines, 4th ed. 2011.


Disclaimer:  This Drug information was designed for use by PIPER Neonatal. Whilst great care has been taken to check the information is accurate, it is possible that errors may have been missed. Furthermore, dosage schedules are continually being revised and new side effects recognised. For these reasons, the reader is strongly advised to consult the drug companies' printed information before administering any of the drugs recommended in this book.
Most drugs in this document are appropriate only for specialist use in hospitals.  A number of drugs should only be used in consultation with the appropriate Paediatric subspecialist. 

Note: The electronic version of this guideline is the version currently in use.  Any printed version cannot be assumed to be current. Printed copies of this document are valid for